Does the media refer more to OSUR or QDEL?

In the previous week, OraSure Technologies had 1 more articles in the media than QuidelOrtho. MarketBeat recorded 2 mentions for OraSure Technologies and 1 mentions for QuidelOrtho. QuidelOrtho's average media sentiment score of 1.67 beat OraSure Technologies' score of 0.71 indicating that QuidelOrtho is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OraSure Technologies 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive QuidelOrtho 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Is OSUR or CERS more profitable?

Cerus has a net margin of -3.06% compared to OraSure Technologies' net margin of -43.70%. Cerus' return on equity of -10.19% beat OraSure Technologies' return on equity. Company Net Margins Return on Equity Return on Assets OraSure Technologies -43.70% -19.09% -16.26% Cerus -3.06% -10.19% -3.14%

Does the media prefer OSUR or CERS?

In the previous week, OraSure Technologies had 1 more articles in the media than Cerus. MarketBeat recorded 2 mentions for OraSure Technologies and 1 mentions for Cerus. Cerus' average media sentiment score of 1.09 beat OraSure Technologies' score of 0.71 indicating that Cerus is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OraSure Technologies 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cerus 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer OSUR or EMBC?

In the previous week, Embecta had 1 more articles in the media than OraSure Technologies. MarketBeat recorded 3 mentions for Embecta and 2 mentions for OraSure Technologies. OraSure Technologies' average media sentiment score of 0.71 beat Embecta's score of 0.00 indicating that OraSure Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OraSure Technologies 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Embecta 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer OSUR or SMTI?

In the previous week, OraSure Technologies had 1 more articles in the media than Sanara MedTech. MarketBeat recorded 2 mentions for OraSure Technologies and 1 mentions for Sanara MedTech. OraSure Technologies' average media sentiment score of 0.71 beat Sanara MedTech's score of 0.34 indicating that OraSure Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OraSure Technologies 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sanara MedTech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate OSUR or ACU?

OraSure Technologies currently has a consensus price target of $3.00, indicating a potential downside of 24.24%. Given OraSure Technologies' higher probable upside, research analysts clearly believe OraSure Technologies is more favorable than Acme United. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OraSure Technologies 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Acme United 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00

Does the media refer more to OSUR or ACU?

In the previous week, Acme United had 2 more articles in the media than OraSure Technologies. MarketBeat recorded 4 mentions for Acme United and 2 mentions for OraSure Technologies. OraSure Technologies' average media sentiment score of 0.71 beat Acme United's score of 0.53 indicating that OraSure Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OraSure Technologies 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Acme United 0 Very Positive mention(s) 4 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

OraSure Technologies (OSUR) Competitors

$3.96 +0.08 (+2.06%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$3.96 +0.00 (+0.13%)

As of 10/2/2026 07:30 PM Eastern

Compare

OSUR vs. QDEL, CERS, EMBC, SMTI, and ACU

Should you buy OraSure Technologies stock or one of its competitors? OraSure Technologies's main competitors and comparable companies include QuidelOrtho (QDEL), Cerus (CERS), Embecta (EMBC), Sanara MedTech (SMTI), and Acme United (ACU). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does OraSure Technologies compare to QuidelOrtho?

OraSure Technologies (NASDAQ:OSUR) and QuidelOrtho (NASDAQ:QDEL) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings.

In the previous week, OraSure Technologies had 1 more articles in the media than QuidelOrtho. MarketBeat recorded 2 mentions for OraSure Technologies and 1 mentions for QuidelOrtho. QuidelOrtho's average media sentiment score of 1.67 beat OraSure Technologies' score of 0.71 indicating that QuidelOrtho is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OraSure Technologies	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
QuidelOrtho	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

OraSure Technologies presently has a consensus price target of $3.00, indicating a potential downside of 24.24%. QuidelOrtho has a consensus price target of $13.63, indicating a potential upside of 26.51%. Given QuidelOrtho's higher possible upside, analysts plainly believe QuidelOrtho is more favorable than OraSure Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OraSure Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
QuidelOrtho	3 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

OraSure Technologies has higher earnings, but lower revenue than QuidelOrtho. OraSure Technologies is trading at a lower price-to-earnings ratio than QuidelOrtho, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OraSure Technologies	$115.02M	2.37	-$68.73M	-$0.69	N/A
QuidelOrtho	$2.73B	0.27	-$1.13B	-$15.41	N/A

QuidelOrtho has a net margin of -39.20% compared to OraSure Technologies' net margin of -43.70%. QuidelOrtho's return on equity of 4.88% beat OraSure Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OraSure Technologies	-43.70%	-19.09%	-16.26%
QuidelOrtho	-39.20%	4.88%	1.63%

93.5% of OraSure Technologies shares are owned by institutional investors. Comparatively, 99.0% of QuidelOrtho shares are owned by institutional investors. 4.7% of OraSure Technologies shares are owned by company insiders. Comparatively, 1.1% of QuidelOrtho shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

OraSure Technologies has a beta of 1.03, meaning that its share price is 3% more volatile than the broader market. Comparatively, QuidelOrtho has a beta of 0.79, meaning that its share price is 21% less volatile than the broader market.

Summary

QuidelOrtho beats OraSure Technologies on 8 of the 14 factors compared between the two stocks.

How does OraSure Technologies compare to Cerus?

OraSure Technologies (NASDAQ:OSUR) and Cerus (NASDAQ:CERS) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, media sentiment, dividends, profitability and analyst recommendations.

93.5% of OraSure Technologies shares are held by institutional investors. Comparatively, 78.4% of Cerus shares are held by institutional investors. 4.7% of OraSure Technologies shares are held by company insiders. Comparatively, 5.3% of Cerus shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Cerus has higher revenue and earnings than OraSure Technologies. Cerus is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OraSure Technologies	$115.02M	2.37	-$68.73M	-$0.69	N/A
Cerus	$206.13M	2.23	-$15.63M	-$0.03	N/A

Cerus has a net margin of -3.06% compared to OraSure Technologies' net margin of -43.70%. Cerus' return on equity of -10.19% beat OraSure Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OraSure Technologies	-43.70%	-19.09%	-16.26%
Cerus	-3.06%	-10.19%	-3.14%

OraSure Technologies has a beta of 1.03, meaning that its stock price is 3% more volatile than the broader market. Comparatively, Cerus has a beta of 1.83, meaning that its stock price is 83% more volatile than the broader market.

In the previous week, OraSure Technologies had 1 more articles in the media than Cerus. MarketBeat recorded 2 mentions for OraSure Technologies and 1 mentions for Cerus. Cerus' average media sentiment score of 1.09 beat OraSure Technologies' score of 0.71 indicating that Cerus is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OraSure Technologies	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cerus	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

OraSure Technologies currently has a consensus target price of $3.00, suggesting a potential downside of 24.24%. Cerus has a consensus target price of $5.25, suggesting a potential upside of 130.26%. Given Cerus' stronger consensus rating and higher possible upside, analysts plainly believe Cerus is more favorable than OraSure Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OraSure Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Cerus	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Cerus beats OraSure Technologies on 12 of the 16 factors compared between the two stocks.

How does OraSure Technologies compare to Embecta?

OraSure Technologies (NASDAQ:OSUR) and Embecta (NASDAQ:EMBC) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

Embecta has a net margin of 8.59% compared to OraSure Technologies' net margin of -43.70%. OraSure Technologies' return on equity of -19.09% beat Embecta's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OraSure Technologies	-43.70%	-19.09%	-16.26%
Embecta	8.59%	-19.25%	10.82%

OraSure Technologies has a beta of 1.03, indicating that its share price is 3% more volatile than the broader market. Comparatively, Embecta has a beta of 0.84, indicating that its share price is 16% less volatile than the broader market.

93.5% of OraSure Technologies shares are held by institutional investors. Comparatively, 93.8% of Embecta shares are held by institutional investors. 4.7% of OraSure Technologies shares are held by company insiders. Comparatively, 1.3% of Embecta shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Embecta had 1 more articles in the media than OraSure Technologies. MarketBeat recorded 3 mentions for Embecta and 2 mentions for OraSure Technologies. OraSure Technologies' average media sentiment score of 0.71 beat Embecta's score of 0.00 indicating that OraSure Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OraSure Technologies	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Embecta	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Embecta has higher revenue and earnings than OraSure Technologies. OraSure Technologies is trading at a lower price-to-earnings ratio than Embecta, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OraSure Technologies	$115.02M	2.37	-$68.73M	-$0.69	N/A
Embecta	$1.08B	0.30	$95.40M	$1.48	3.82

OraSure Technologies currently has a consensus target price of $3.00, suggesting a potential downside of 24.24%. Embecta has a consensus target price of $11.00, suggesting a potential upside of 94.69%. Given Embecta's stronger consensus rating and higher probable upside, analysts plainly believe Embecta is more favorable than OraSure Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OraSure Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Embecta	2 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.60

Summary

Embecta beats OraSure Technologies on 10 of the 15 factors compared between the two stocks.

How does OraSure Technologies compare to Sanara MedTech?

OraSure Technologies (NASDAQ:OSUR) and Sanara MedTech (NASDAQ:SMTI) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, valuation, dividends, earnings and analyst recommendations.

Sanara MedTech has lower revenue, but higher earnings than OraSure Technologies. Sanara MedTech is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OraSure Technologies	$115.02M	2.37	-$68.73M	-$0.69	N/A
Sanara MedTech	$103.12M	3.11	-$37.56M	-$3.59	N/A

OraSure Technologies currently has a consensus price target of $3.00, suggesting a potential downside of 24.24%. Sanara MedTech has a consensus price target of $35.00, suggesting a potential upside of 0.43%. Given Sanara MedTech's stronger consensus rating and higher possible upside, analysts plainly believe Sanara MedTech is more favorable than OraSure Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OraSure Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Sanara MedTech	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80

93.5% of OraSure Technologies shares are held by institutional investors. Comparatively, 8.1% of Sanara MedTech shares are held by institutional investors. 4.7% of OraSure Technologies shares are held by company insiders. Comparatively, 42.0% of Sanara MedTech shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

OraSure Technologies has a beta of 1.03, suggesting that its stock price is 3% more volatile than the broader market. Comparatively, Sanara MedTech has a beta of 1.19, suggesting that its stock price is 19% more volatile than the broader market.

Sanara MedTech has a net margin of -29.15% compared to OraSure Technologies' net margin of -43.70%. Sanara MedTech's return on equity of 29.72% beat OraSure Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OraSure Technologies	-43.70%	-19.09%	-16.26%
Sanara MedTech	-29.15%	29.72%	2.84%

In the previous week, OraSure Technologies had 1 more articles in the media than Sanara MedTech. MarketBeat recorded 2 mentions for OraSure Technologies and 1 mentions for Sanara MedTech. OraSure Technologies' average media sentiment score of 0.71 beat Sanara MedTech's score of 0.34 indicating that OraSure Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OraSure Technologies	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sanara MedTech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Sanara MedTech beats OraSure Technologies on 9 of the 15 factors compared between the two stocks.

How does OraSure Technologies compare to Acme United?

OraSure Technologies (NASDAQ:OSUR) and Acme United (NYSE:ACU) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation and earnings.

OraSure Technologies currently has a consensus price target of $3.00, indicating a potential downside of 24.24%. Given OraSure Technologies' higher probable upside, research analysts clearly believe OraSure Technologies is more favorable than Acme United.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OraSure Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Acme United	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	4.00

Acme United has higher revenue and earnings than OraSure Technologies. OraSure Technologies is trading at a lower price-to-earnings ratio than Acme United, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OraSure Technologies	$115.02M	2.37	-$68.73M	-$0.69	N/A
Acme United	$211.60M	1.14	$17.79M	$2.38	26.68

93.5% of OraSure Technologies shares are held by institutional investors. Comparatively, 62.1% of Acme United shares are held by institutional investors. 4.7% of OraSure Technologies shares are held by company insiders. Comparatively, 29.5% of Acme United shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

OraSure Technologies has a beta of 1.03, meaning that its share price is 3% more volatile than the broader market. Comparatively, Acme United has a beta of 0.4, meaning that its share price is 60% less volatile than the broader market.

Acme United has a net margin of 10.25% compared to OraSure Technologies' net margin of -43.70%. Acme United's return on equity of 9.70% beat OraSure Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OraSure Technologies	-43.70%	-19.09%	-16.26%
Acme United	10.25%	9.70%	6.10%

In the previous week, Acme United had 2 more articles in the media than OraSure Technologies. MarketBeat recorded 4 mentions for Acme United and 2 mentions for OraSure Technologies. OraSure Technologies' average media sentiment score of 0.71 beat Acme United's score of 0.53 indicating that OraSure Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OraSure Technologies	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Acme United	0 Very Positive mention(s)	4 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Acme United beats OraSure Technologies on 11 of the 16 factors compared between the two stocks.

Get OraSure Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OSUR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OSUR vs. The Competition

Export

Metric	OraSure Technologies	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$273.46M	$5.48B	$7.15B	$13.28B
Dividend Yield	N/A	1.81%	2.54%	17.33%
P/E Ratio	-5.74	25.42	274.71	26.04
Price / Sales	2.37	67.70	656.46	105.16
Price / Cash	N/A	32.27	78.87	52.62
Price / Book	0.83	5.73	10.93	6.31
Net Income	-$68.73M	$152.68M	$3.51B	$362.16M
7 Day Performance	0.76%	-1.71%	-2.00%	-1.66%
1 Month Performance	13.79%	-4.87%	-6.19%	-4.68%
1 Year Performance	24.53%	1.30%	8.03%	1.57%

OraSure Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OSUR OraSure Technologies	1.0009 of 5 stars	$3.96 +2.1%	$3.00 -24.2%	+24.5%	$273.46M	$115.02M	N/A	500
QDEL QuidelOrtho	3.028 of 5 stars	$10.60 -2.2%	$13.63 +28.6%	-64.1%	$726.50M	$2.73B	N/A	6,500
CERS Cerus	1.858 of 5 stars	$2.47 +0.6%	$5.25 +113.0%	+45.2%	$496.34M	$206.13M	N/A	345	News Coverage
EMBC Embecta	3.525 of 5 stars	$5.81 -2.1%	$11.00 +89.5%	-60.5%	$328.91M	$1.08B	3.92	1,850
SMTI Sanara MedTech	0.4115 of 5 stars	$35.08 -0.1%	$35.00 -0.2%	+11.7%	$322.33M	$103.12M	N/A	108	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OSUR) was last updated on 10/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

OraSure Technologies (OSUR) Competitors

OSUR vs. QDEL, CERS, EMBC, SMTI, and ACU

How does OraSure Technologies compare to QuidelOrtho?

Summary

How does OraSure Technologies compare to Cerus?

Summary

How does OraSure Technologies compare to Embecta?

Summary

How does OraSure Technologies compare to Sanara MedTech?

Summary

How does OraSure Technologies compare to Acme United?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OSUR vs. The Competition

OraSure Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

OraSure Technologies (OSUR) Competitors

OSUR vs. QDEL, CERS, EMBC, SMTI, and ACU

How does OraSure Technologies compare to QuidelOrtho?

Does the media refer more to OSUR or QDEL?

Do analysts prefer OSUR or QDEL?

Which has better valuation & earnings, OSUR or QDEL?

Is OSUR or QDEL more profitable?

Do insiders & institutionals believe in OSUR or QDEL?

Which has more risk and volatility, OSUR or QDEL?

Summary

How does OraSure Technologies compare to Cerus?

Do insiders and institutionals have more ownership in OSUR or CERS?

Which has preferable valuation & earnings, OSUR or CERS?

Is OSUR or CERS more profitable?

Which has more risk & volatility, OSUR or CERS?

Does the media prefer OSUR or CERS?

Do analysts prefer OSUR or CERS?

Summary

How does OraSure Technologies compare to Embecta?

Is OSUR or EMBC more profitable?

Which has more volatility and risk, OSUR or EMBC?

Do institutionals and insiders have more ownership in OSUR or EMBC?

Does the media prefer OSUR or EMBC?

Which has better valuation and earnings, OSUR or EMBC?

Do analysts rate OSUR or EMBC?

Summary

How does OraSure Technologies compare to Sanara MedTech?

Which has better valuation & earnings, OSUR or SMTI?

Do analysts prefer OSUR or SMTI?

Do insiders & institutionals have more ownership in OSUR or SMTI?

Which has more risk and volatility, OSUR or SMTI?

Is OSUR or SMTI more profitable?

Does the media prefer OSUR or SMTI?

Summary

How does OraSure Technologies compare to Acme United?

Do analysts rate OSUR or ACU?

Which has stronger earnings and valuation, OSUR or ACU?

Do institutionals & insiders believe in OSUR or ACU?

Which has more volatility and risk, OSUR or ACU?

Is OSUR or ACU more profitable?

Does the media refer more to OSUR or ACU?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OSUR vs. The Competition

OraSure Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools